Abivax (ABVX) Treasury Shares (2024)

Abivax's (ABVX) quarterly Treasury Shares came in at $131786.3 in Q3 2024, up 413.79% quarter-over-quarter from -$41998.6 in Q2 2024.

Abivax (ABVX) Treasury Shares (2024) Analysis & Trends

Abivax's Treasury Shares history runs 1 years deep, the most recent figure standing at $131786.3 for Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-21,709.08
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	265,401.92
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	19.41 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	5.14 Mn
10	Abivax	10.36 Bn	10.36 Bn	-	-

Download Data